Locus Biosciences

Precision phage therapeutics.

Morrisville, United States · Founded 2015 · $84.9M raised

Employees
51–200
Founded
2015
Business Model
B2B
Total Funding
$84.9M
Last Round
$7.0M SeedMay 2022
Rounds
4

About

Locus Biosciences is a clinical-stage precision medicine company developing engineered bacteriophage products that selectively remove disease-causing pathogenic bacteria from the human body. Using a proprietary CRISPR-Cas3 platform combined with high-throughput phage engineering, the company is advancing therapeutics for serious bacterial infections and microbiome indications. Locus conducted the world's first clinical trial of a recombinant CRISPR bacteriophage therapy and is headquartered in Morrisville, North Carolina.

Summary

Locus Biosciences is a Biotech company based in Morrisville, United States, founded in 2015. It has raised $84.9M in total across 4 rounds, most recently a $7.0M Seed round in May 2022. Investors include Artis Ventures (AV), Biomedical Advanced Research and Development Authority (BARDA) and Hercules Capital.

Funding History

Sign up to view the funding chart

Create a free account with 25 free credits every month, no card needed, to unlock funding history, valuations, and tech stacks.

Series BSeries BMay 2022
$35.0M

Sign up to see all 5 rounds

Seed through Series B — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Locus Biosciences on Indexed.vc
<a href="https://indexed.vc/companies/locus-biosciences"><img src="https://indexed.vc/api/badge/company/locus-biosciences" alt="Locus Biosciences on Indexed.vc" width="260" height="76" /></a>